September 2, 2026 · Zenodo (CERN European Organization for Nuclear Research)Dissecting the limitations of AlphaFold3 confidence metrics for de novo antibody design selectionanonymousDiscovered via OpenAlex Highlighted authors matched this feed. AbstractNo abstract is available for this publication. Read full article ↗View raw RSS